ITM Isotopen Technologien München received the "Most Innovative Product" award in the Startups category of Pharma Trend 2018. Second place went to moio.care, the intelligent care plaster. Third place went to ello, the electric walker.
The jury evaluated submissions from startups in biotechnology, medical technology, and digital health and honored the top three products and projects with the "Most Innovative Product" award. The awards ceremony for the specialist categories took place for the 19th time as part of the Pharma Trend Image and Innovation Award with the publication of the "Best Pharmaceutical Companies in Germany" ranking on September 18, 2018, at the Deutsches Museum in Munich. The ranking is based on the Pharma Trend survey, which has been conducted annually since 2000.
Winner of “Most Innovative Product” in the Startups category
When evaluating the products and projects submitted by startups, the jury considered criteria such as patient benefit, innovativeness, efficiency in patient care, and transfer into standard care. This year, the following products were honored with the "Most Innovative Product" award:
- Radionuclides and radiopharmaceuticals, ITM Isotope Technologies Munich, Garching near Munich (Biotechnology)
- care, MOIO, Fürth (digital health)
- ello, eMovements, Stuttgart (medical technology)
Biotechnology: Radionuclides and Radiopharmaceuticals from ITM
ITM Isotopen Technologien München AG (ITM) develops, produces, and markets innovative diagnostic and therapeutic radionuclides and radiopharmaceuticals worldwide. Since its founding in 2004, ITM and its subsidiaries have been developing and expanding a platform of innovative, first-class medical radionuclides and generators for targeted cancer diagnosis and therapy. ITM's primary objective is to improve treatment outcomes and the quality of life for cancer patients and reduce side effects. By developing targeted radionuclide therapies in precision oncology, ITM aims to make a long-term contribution to achieving health economic improvements and generating sustainable social benefits.
You can find more information about the Pharma Trend at www.pharma-trend.com.
